Hisamitsu Pharmaceutical Co., Inc.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1847-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.hisamitsu.co.jp
Clinical Trials
62
Active:0
Completed:30
Trial Phases
4 Phases
Phase 1:3
Phase 2:15
Phase 3:34
+1 more phases
Drug Approvals
8
CANADA:3
PHILIPPINES:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (55 trials with phase data)• Click on a phase to view related trials
Phase 3
34 (61.8%)Phase 2
15 (27.3%)Phase 1
3 (5.5%)phase_1_2
1 (1.8%)phase_2_3
1 (1.8%)Phase 4
1 (1.8%)Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail
Phase 2
Completed
- Conditions
- Onychomycosis
- Interventions
- Drug: HTU-520 PatchOther: Placebo Patch
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Target Recruit Count
- 182
- Registration Number
- NCT01400594
- Locations
- 🇺🇸
Total Skin and Beauty Dermatology Center, Birmingham, Alabama, United States
🇺🇸Radiant Research, Inc., San Antonio, Texas, United States
🇺🇸UAB Department of Dermatology, Birmingham, Alabama, United States
FS-67 in the Treatment of Pediatric Patients With Ankle Sprain
Phase 4
Completed
- Conditions
- Ankle Sprain
- Interventions
- Drug: FS-67 PatchOther: Placebo Patch
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Target Recruit Count
- 252
- Registration Number
- NCT01037816
- Locations
- 🇺🇸
Hisamitsu Investigator Site, Grapevine, Texas, United States
HKT-500 in the Treatment of Adult Patients With Ankle Sprain
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00927641
- Locations
- 🇺🇸
Hisamitsu Investigator Site, Danville, Virginia, United States
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
Phase 3
Completed
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Other: Placebo Patch
- First Posted Date
- 2008-11-18
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Target Recruit Count
- 380
- Registration Number
- NCT00792727
- Locations
- 🇺🇸
Hisamitsu Investigator Site, Yakima, Washington, United States
HKT-500 in Adult Patients With Ankle Sprain
Phase 3
Completed
- Conditions
- Ankle Sprain
- Interventions
- Drug: HKT-500 Ketoprofen Topical PatchOther: Placebo Patch
- First Posted Date
- 2008-05-20
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Target Recruit Count
- 260
- Registration Number
- NCT00680784
- Locations
- 🇺🇸
Hisamitsu Investigator Site., Bellevue, Washington, United States
- Prev
- 1
- 2
- Next
News
No news found